Allergan, Inc. News Headlines

AGN 
$163.68
*  
1.57
0.97%
Get AGN Alerts
*Delayed - data as of Aug. 29, 2014  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

RLJ Lodging Boosts West Coast Presence - Analyst Blog
5/27/2014 11:10:00 AM - Zacks.com

Pfizer Pulls Out of AstraZeneca Deal - Analyst Blog
5/27/2014 10:35:00 AM - Zacks.com

Pipeline Progress at RedHill Biopharma - Analyst Blog
5/23/2014 6:00:00 PM - Zacks.com

Pfizer, BioRestorative Therapies Ink Deal - Analyst Blog
5/23/2014 5:30:00 PM - Zacks.com

Healthcare Stocks Slightly Higher Near Close; Allergan Rising After Barron's Makes Case for Higher Buyout Price
5/23/2014 4:00:49 PM - MT Newswires

Sector Update: Healthcare
5/23/2014 4:00:11 PM - MT Newswires

Novartis Settles Litigation Agreement with Acura - Analyst Blog
5/23/2014 12:10:00 PM - Zacks.com

Data on Insmed's Arikayce - Analyst Blog
5/22/2014 4:30:00 PM - Zacks.com

Data on Novartis' Ultibro Breezhaler - Analyst Blog
5/21/2014 6:30:00 PM - Zacks.com

Valeant: Poor Earnings Quality Masked By Acquisition Related Pro-Forma Reporting
5/21/2014 6:08:00 PM - Seeking Alpha

Intercept Sinks on Cholesterol Issue - Analyst Blog
5/21/2014 5:12:00 PM - Zacks.com

AbbVie's Humira Gets Orphan Drug Designation - Analyst Blog
5/21/2014 4:30:00 PM - Zacks.com

Why Ackman exited Procter and Gamble stake?
5/21/2014 1:00:00 PM - Market Realist

Why Pershing exited General Growth Properties in 1Q14
5/21/2014 9:00:00 AM - Market Realist

Novartis, Ophthotech Sign Deal for Fovista - Analyst Blog
5/20/2014 6:15:00 PM - Zacks.com

Glaxo-Genmab's Arzerra Disappoints - Analyst Blog
5/20/2014 5:50:00 PM - Zacks.com

Why Ackman teamed up with Valeant to bid for Allergan
5/20/2014 5:00:00 PM - Market Realist

Canada Stocks Close Higher; Valeant Gives Market Shot In The Arm
5/20/2014 4:02:20 PM - MT Newswires

TECHNICAL ANALYSIS: Canadian Stocks Edge Lower; Sectors Mixed; Healthcare With Valeant A Stand Out Gainer
5/20/2014 2:17:27 PM - MT Newswires

Why Ackman started position in Home Properties
5/20/2014 1:00:00 PM - Market Realist

Sector Update: Healthcare; Cardiome Signs Deal for AGGRASTAT, Valeant Offer for Allergan Shares Not All Cash As Expected
5/20/2014 12:17:48 PM - MT Newswires

TSX Up 49 Points at Midday; Healthcare Strongest Sector on Valeant Boost
5/20/2014 12:08:09 PM - MT Newswires

FDA Designation for Bristol-Myers/AbbVie Candidate - Analyst Blog
5/20/2014 11:40:00 AM - Zacks.com

Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for May 21, 2014
5/20/2014 9:00:02 AM - NASDAQ.com News

Why Pershing opened new position in AIMCO
5/20/2014 9:00:00 AM - Market Realist